Immediate early events of the HPV life cycle
HPV 生命周期的早期事件
基本信息
- 批准号:10163808
- 负责人:
- 金额:$ 33.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAppearanceBasal CellBasement membraneBenignBindingCancerousCapsid ProteinsCell CompartmentationCell Culture TechniquesCell CycleCell Differentiation processCell LineCell NucleusCellsCervix carcinomaClone CellsDNADepositionDermalDevelopmentEarly PromotersEpithelialEpithelial CellsEventExtracellular MatrixFutureGene ExpressionGenerationsGenesGenetic ScreeningGenomeGrowthHumanHuman PapillomavirusHuman papilloma virus infectionHuman papillomavirus 16InfectionInvestigationKnock-outLate PromotersLesionLife Cycle StagesMaintenanceMalignant NeoplasmsMeasuresMethylcelluloseModelingMucous MembraneNuclearOncogene DeregulationOncogenesOncoproteinsPapillomaPlayPrimary InfectionProcessProductionRegulationRepressionRoleSkinStratified EpitheliumStratum BasaleSystemTestingTonsilTranscriptTranscriptional RegulationTransfectionUndifferentiatedViralViral GenesViral GenomeViral OncogeneViral PhysiologyViral ProteinsVirionVirusbasecell immortalizationdifferential expressionestablished cell linegenetic analysisgenetic manipulationhigh riskimprovedinnovationkeratinocytemonolayermutantnext generationpenis foreskinpremalignantpreventprogramspromotertherapy developmenttooltranscriptome sequencingtumorwound
项目摘要
Human papillomaviruses (HPV) replicate in stratified epithelia of the skin and mucosa and require the terminal
differentiation program to complete their lifecycle. HPV access the basal cells of these epithelia through lesions
and establish infection after genome delivery to the nucleus and initial genome amplification. In the basal cell
compartment of productive infections, genome levels are maintained and early viral transcript levels are low.
Early, intermediate and late transcripts as well as genome levels increase when infected cells enter the
terminal differentiation program. The E6 and E7 oncoproteins prevent differentiated cells from exiting the cell
cycle, resulting in the appearance of the benign lesions typically associated with HPV infection (warts,
papillomas) and allowing genome amplification, late gene expression and virus production. However, some
HPV types including HPV16 are associated with malignancies such as cervical carcinoma. HPV-induced
transformation is initiated with the deregulation of oncogene expression in the long-lived, replication-competent
cells of the basal layer. While we do have a very good understanding of E6 and E7 function during
transformation, the lack of appropriate cell culture models have prevented us from studying immediate early
events following infection of basal cells. Most studies of the HPV life cycle depend on keratinocytes-derived
cell lines established from low-grade lesions or after transfection of viral genome into primary keratinocytes
and outgrowth of HPV DNA-containing cell clones. In contrast to basal cells in productive lesions, HPV-
immortalized cell lines express high levels of the E6 and E7 oncoproteins, which is a requirement for
immortalization. The study of such cell lines allowed an understanding of differentiation-induced changes to
viral gene expression, genome amplification and the role early viral proteins play in this process. However,
many questions regarding early events during the establishment of HPV infection as well as early events of
viral transformation remain unanswered.
Based on our intimate studies of attachment, binding and internalization of HPV16 virions by keratinocytes and
our capability to generate virions using heterologous expression systems, we have now established an
infection model that allows efficient infection of primary human foreskin keratinocytes (HFK) with HPV16
quasivirions. The model mimics natural infection in that (i) it utilizes prebinding of virions to extracellular matrix,
the basement membrane-equivalent; (ii) allows efficient delivery of viral genome to PML nuclear bodies, (iii)
only the early but not the late promoter is active in undifferentiated HFK; (iv) early and late promoter are
responsive to differentiation triggered by growth in methylcellulose or organotypic raft cultures resulting in high
levels of late transcripts; (v) viral genome remains episomal and is amplified upon differentiation; (vi) and
capsid proteins are expressed in the upper layers of organotypic raft cultures derived from HPV16-infected
HFK. Thus, the infection model is the first cell culture model to recapitulate the complete viral lifecycle. Since
the early promoter is upregulated upon differentiation, we assume that the infection model also mimics early
promoter repression observed in naturally infected lesions. We have gathered preliminary evidence using next
generation RNA sequencing that only a very limited subset of host cell genes is differentially expressed in
HPV16-infected HFK as opposed to thousands of genes in HPV16-immortalized HFK. Because the infection
model uses quasivirions generated in the 293TT production cell line, which does not depend on any non-
structural HPV factor for virus production, it is amenable to extensive genetic manipulations. In turn, this allows
the characterization of viral factors involved in the immediate early events of HPV16 infection. We have prove-
of-principal that mutant viruses can be generated and found evidence that E7 knockout affects early and late
viral promoter activity in monolayer and differentiated HFK cells, respectively. We propose to utilize the
infection model to determine the role of viral and host cell factors in genome amplification and regulation of
early promoter activity (Aim1); delineate the contributions of E6 and E7 to the HPV16 lifecycle (Aim 2); and
compare the contributions of E6 and E7 to the lifecycles of low- and high-risk HPV types (Aim 3). The
proposed studies will help fill huge gaps in the understanding of immediate early events of the HPV lifecycle.
They will also help to gain a better understanding of the often hypothesized but never experimentally tested
repression of oncogene expression in the basal cell layer during natural infection and the role viral proteins
play during this process. In future, this model will allow investigating the deregulation of viral oncogene
expression during initial events of transformation. The infection model has the potential to be as important for
the study of immediate early events of the HPV16 lifecycle and transformation as the establishment of HPV-
harboring keratinocytes was for understanding the late differentiation-induced stages.
人乳头瘤病毒 (HPV) 在皮肤和粘膜的复层上皮细胞中复制,需要末端
差异化计划来完成其生命周期。 HPV 通过病变进入这些上皮的基底细胞
并在基因组递送至细胞核和初始基因组扩增后建立感染。在基底细胞中
在生产性感染区室中,基因组水平得以维持,早期病毒转录水平较低。
当受感染的细胞进入细胞时,早期、中期和晚期转录物以及基因组水平都会增加
终端分化计划。 E6 和 E7 癌蛋白阻止分化细胞离开细胞
周期,导致出现通常与 HPV 感染相关的良性病变(疣、
乳头状瘤)并允许基因组扩增、晚期基因表达和病毒产生。然而,一些
包括 HPV16 在内的 HPV 类型与宫颈癌等恶性肿瘤有关。 HPV诱导的
转化是随着长寿、具有复制能力的细胞中癌基因表达的失调而开始的。
基底层细胞。虽然我们在使用过程中确实对E6和E7的功能有了很好的了解
由于缺乏合适的细胞培养模型,我们无法立即进行转化研究
基底细胞感染后的事件。大多数 HPV 生命周期的研究依赖于角质形成细胞衍生的
从低度病变或将病毒基因组转染至原代角质形成细胞后建立的细胞系
以及含有 HPV DNA 的细胞克隆的生长。与生产性病变中的基底细胞相比,HPV-
永生化细胞系表达高水平的 E6 和 E7 癌蛋白,这是
永生化。对此类细胞系的研究使我们能够了解分化诱导的变化
病毒基因表达、基因组扩增以及早期病毒蛋白在此过程中发挥的作用。然而,
关于 HPV 感染期间的早期事件以及 HPV 感染的早期事件的许多问题
病毒转化仍然没有答案。
基于我们对 HPV16 病毒颗粒通过角质形成细胞的附着、结合和内化的深入研究,
由于我们有能力使用异源表达系统产生病毒粒子,我们现在已经建立了一个
允许用 HPV16 有效感染原代人包皮角质形成细胞 (HFK) 的感染模型
准病毒粒子。该模型模拟自然感染,因为(i)它利用病毒粒子与细胞外基质的预结合,
基底膜等效物; (ii) 允许将病毒基因组有效递送至 PML 核体,(iii)
在未分化的 HFK 中,只有早期启动子有活性,而晚期启动子则没有活性; (iv) 早期和晚期启动子
对甲基纤维素或器官筏培养物中的生长引发的分化作出反应,从而导致高
晚期成绩单的水平; (v) 病毒基因组保持游离状态并在分化时扩增; (六) 和
衣壳蛋白在 HPV16 感染的器官型筏培养物的上层表达
HFK。因此,感染模型是第一个概括完整病毒生命周期的细胞培养模型。自从
早期启动子在分化时上调,我们假设感染模型也模仿早期
在自然感染的病变中观察到启动子抑制。我们已经使用下一步收集了初步证据
一代 RNA 测序表明,只有非常有限的宿主细胞基因子集在
HPV16 感染的 HFK 与 HPV16 永生化 HFK 中的数千个基因不同。因为感染
模型使用 293TT 生产细胞系中生成的准病毒粒子,该细胞系不依赖于任何非
作为病毒产生的 HPV 结构因子,它适合广泛的基因操作。反过来,这允许
HPV16 感染早期事件中涉及的病毒因素的特征。我们已经证明——
原则上可以产生突变病毒,并发现 E7 敲除影响早期和晚期的证据
分别在单层和分化的 HFK 细胞中病毒启动子活性。我们建议利用
感染模型以确定病毒和宿主细胞因子在基因组扩增和调节中的作用
早期启动子活性(目标1);描述 E6 和 E7 对 HPV16 生命周期的贡献(目标 2);和
比较 E6 和 E7 对低危和高危 HPV 类型生命周期的贡献(目标 3)。这
拟议的研究将有助于填补对 HPV 生命周期早期事件理解的巨大空白。
它们还将有助于更好地理解经常假设但从未经过实验测试的问题
自然感染过程中基底细胞层癌基因表达的抑制以及病毒蛋白的作用
在此过程中进行游戏。将来,该模型将允许研究病毒癌基因的失调
转化初始事件期间的表达。感染模型有可能同样重要
随着HPV-16的建立,研究HPV16生命周期和转化的早期事件
含有角质形成细胞是为了了解晚期分化诱导阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Sapp其他文献
Martin Sapp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Sapp', 18)}}的其他基金
Epigenetics of dysfunctional oral epithelium in people living with HIV and risk for HPV infection
HIV 感染者口腔上皮功能障碍的表观遗传学和 HPV 感染风险
- 批准号:
10709070 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
Human papillomavirus entry: late trafficking and establishment of infection
人乳头瘤病毒进入:晚期贩运和感染建立
- 批准号:
10655496 - 财政年份:2021
- 资助金额:
$ 33.17万 - 项目类别:
Human papillomavirus entry: late trafficking and establishment of infection
人乳头瘤病毒进入:晚期贩运和感染建立
- 批准号:
10316816 - 财政年份:2021
- 资助金额:
$ 33.17万 - 项目类别:
Human papillomavirus entry: late trafficking and establishment of infection
人乳头瘤病毒进入:晚期贩运和感染建立
- 批准号:
10436998 - 财政年份:2021
- 资助金额:
$ 33.17万 - 项目类别:
Cell surface events of human papillomavirus type 16 and 18 infection
人乳头瘤病毒 16 型和 18 型感染的细胞表面事件
- 批准号:
7895816 - 财政年份:2009
- 资助金额:
$ 33.17万 - 项目类别:
Cell surface events of human papillomavirus type 16 and 18 infection
人乳头瘤病毒 16 型和 18 型感染的细胞表面事件
- 批准号:
7740732 - 财政年份:2009
- 资助金额:
$ 33.17万 - 项目类别:
Cell surface events of human papillomavirus type 16 and 18 infection
人乳头瘤病毒 16 型和 18 型感染的细胞表面事件
- 批准号:
8289413 - 财政年份:2009
- 资助金额:
$ 33.17万 - 项目类别:
Cell surface events of human papillomavirus type 16 and 18 infection
人乳头瘤病毒 16 型和 18 型感染的细胞表面事件
- 批准号:
8500124 - 财政年份:2009
- 资助金额:
$ 33.17万 - 项目类别:
Cell surface events of human papillomavirus type 16 and 18 infection
人乳头瘤病毒 16 型和 18 型感染的细胞表面事件
- 批准号:
8078821 - 财政年份:2009
- 资助金额:
$ 33.17万 - 项目类别:
相似国自然基金
干旱内陆河高含沙河床对季节性河流入渗的影响机制
- 批准号:52379031
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
沿纬度梯度冠层结构多样性变化对森林生产力的影响
- 批准号:32371610
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
开放与二元结构下的中国工业化:对增长与分配的影响机制研究
- 批准号:72373005
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
基于MF和HPLC-ICP-MS监测蛋白冠形成与转化研究稀土掺杂上转换纳米颗粒对凝血平衡的影响机制
- 批准号:82360655
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
高寒草灌植被冠层与根系结构对三维土壤水分动态的影响研究
- 批准号:42301019
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatialomics and quantitative MRI of ischemic injury in a piglet model of Legg-Calve-Perthes disease
Legg-Calve-Perthes 病仔猪模型缺血性损伤的空间组学和定量 MRI
- 批准号:
10806492 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
Developing and Testing a Cross-Cultural Measure of Gender Norms and Mental Health in Adolescence
开发和测试青春期性别规范和心理健康的跨文化衡量标准
- 批准号:
10727749 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
Developing a new platform to characterize and treat disease-associated polycystin variants
开发一个新平台来表征和治疗与疾病相关的多囊蛋白变体
- 批准号:
10726754 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
Targeting proteoglycan-mediated signaling in Ewing sarcoma
尤文肉瘤中靶向蛋白多糖介导的信号传导
- 批准号:
10591979 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease
肥胖对 SARS-COV-2 感染的影响以及 SARS-COV-2 对代谢疾病的相互影响
- 批准号:
10583175 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别: